Evaluation of inhaler use technique among patients with chronic obstructive pulmonary disease

Document Type : Original Article


1 Pulmonologist, Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

2 Department of Medical Education, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

3 Pulmonologist, Lung Diseases Research Center, Division of Sleep Medicine, Psychiatry and Behavioral Sciences Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.


Introduction: Chronic obstructive pulmonary disease (COPD) is a common medical problem. The improper implementation of inhaler techniques thatare used in such patients leads to the reduced effect of medicines. This study was conducted to evaluate the correct use of various inhalers among COPD patients.
Materials and Methods:This observational, cross-sectional study was carried out on 96 patients with COPD aged over 40 years. The samples were selected using asystematic random samplingmethod from patients with COPD referring to the clinics of Ghaem and Imam Reza hospitals, Mashhad, Iran, from March 2018 to March 2019. The subjects were informed that their participation in the study was voluntary. These cases were under the treatment of using at least one inhaled medicine for a month or more. The adopted technique of applying four types of inhalers was evaluated by a standard checklist. The patients' performance scores of all procedures were recorded, and the collected data were analyzed in SPSS software (version 16).
Results: Our study revealed that more than 98% of patients used metered-dose inhaler (MDI) spray (P=0.05). The patients' scores on the correct use of MDI, Diskus, Turbuhaler, and HandiHaler inhalers were estimated at 68, 77, 87, and 90%, respectively. The most common mistakes in using MDI and HandiHaler inhalers were related to the 'holding the breath' and "taking a deep inhale' steps after using the inhaler, respectively.
Conclusion: Physicians must evaluate and modify the use of inhalers in every COPD patient. It is recommended that easy-to-use inhalers, such as HandiHaler, be prescribed for such patients.


1.             Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. American journal of respiratory and critical care medicine. 2017;195(5):557-82.
2.             Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. The European respiratory journal. 2006;27(2):397-412.
3.             Medicine GCRDCJTLR. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. 2017;5(9):691.
4.             Broaddus VC MR, Ernst JD, King TE, Lazarus SC, Murray JF, Nadel JA, Slutsky A, Gotway M. Murray & Nadel's Textbook of Respiratory Medicine E-Book. Elsevier Health Sciences; 2015 Mar 17.
5.             Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American journal of respiratory and critical care medicine. 2013;187(4):347-65.
6.             Long-term oxygen therapy for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis. Ontario health technology assessment series. 2012;12(7):1-64.
7.             Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respiratory medicine. 2008;102(4):593-604.
8.             Rau JL. Practical problems with aerosol therapy in COPD. Respiratory care. 2006;51(2):158-72.
9.             Press VG, Arora VM, Shah LM, Lewis SL, Charbeneau J, Naureckas ET, et al. Teaching the use of respiratory inhalers to hospitalized patients with asthma or COPD: a randomized trial. 2012;27(10):1317-25.
10.          Mahon J, Fitzgerald A, Glanville J, Dekhuijzen R, Glatte J, Glanemann S, et al.Misuse and/or treatment delivery failure of inhalers among patients with asthma or COPD: A review and recommendations for the conduct of future research. Respiratory medicine. 2017;129:98-116.
11.          Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, RauJL, et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005;127(1):335-71.
12.          Paasche-Orlow MK, Riekert KA, Bilderback A, Chanmugam A, Hill P, Rand CS, et al. Tailored education may reduce health literacy disparities in asthma self-management. American journal of respiratory and critical care medicine. 2005;172(8):980-6.
13.          Effing T, Monninkhof EM, van der Valk PD, van der Palen J, van Herwaarden CL, Partidge MR, et al. Self-management education for patients with chronic obstructive pulmonary disease. The Cochrane database of systematic reviews. 2007(4):Cd002990.
14.          Chrystyn H, van der Palen J, Sharma R, Barnes N, Delafont B, Mahajan A, et al. Device errors in asthma and COPD: systematic literature review and meta-analysis. NPJ primary care respiratory medicine. 2017;27(1):22.
15.          Batterink J, Dahri K, Aulakh A, Rempel C. Evaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary disease. The Canadian journal of hospital pharmacy. 2012;65(2):111-8.
16.          Mehuys E, Boussery K, Adriaens E, Van Bortel L, De Bolle L, Van Tongelen I, et al. COPD management in primary care: an observational, community pharmacy-based study. The Annals of pharmacotherapy. 2010;44(2):257-66.
17.          Melzer AC, Ghassemieh BJ, Gillespie SE, Lindenauer PK, McBurnie MA, Mularski RA, et al. Patient characteristics associated with poor inhaler technique among a cohortof patients with COPD. 2017;123:124-30.
18.          Beigoli S, Sharifi Rad A, Askari A, Assaran Darban R, Chamani J. Isothermal titration calorimetry and stopped flow circular dichroism investigations of the interaction between lomefloxacin and human serum albumin in the presence of amino acids. Journal of Biomolecular Structure & Dynamics. 2019;37(9):2265-2282.
19.          Press VG, Arora VM, Shah LM, Lewis SL, Ivy K, Charbeneau J, et al. Misuse of respiratory inhalers in hospitalized patients with asthma or COPD. Journal of general internal medicine. 2011;26(6):635-42.
20.          Lee H, Boo S, Lim Y, Kim S, Kim I-AJCnr. Accuracy of inhaler use in patients with chronic obstructive pulmonary disease. 2014;23(5):560-74.
21.          Rootmensen GN, Van Keimpema AR, Jansen HM, de Haan RJJJoam, delivery pd. Predictors of incorrect inhalation technique in patients with asthma or COPD: a study using a validated videotaped scoring method. 2010;23(5):323-8.
22.          Bosnic-Anticevich SZ, Sinha H, So S, Reddel HKJJoA. Metered-dose inhaler technique: the effect of two educational interventions delivered in community pharmacy over time. 2010;47(3):251-6.
23.          Molimard M, Raherison C, Lignot S,Depont F, Abouelfath A, Moore NJJoam. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. 2003;16(3):249-54.
24.          van Beerendonk I, Mesters I, Mudde AN, Tan TJJoA. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. 1998;35(3):273-9.
25.          Wieshammer S, Dreyhaupt JJR. Dry powder inhalers: which factors determine the frequency of handling errors? 2008;75(1):18-25.
26.          Broeders ME, Molema J, Hop WC, Vermue NA, Folgering HTMJRm. The course of inhalation profiles during an exacerbation of obstructive lung disease. 2004;98(12):1173-9.
27.          Danesh N, Navaee Sedighi Z, Beigoli S, Sharifi-Rad A, Saberi MR, Chamani J. Determining the binding site and binding affinity of estradiol to human serum albumin and holo-transferrin: fluorescence spectroscopic, isothermal titration calorimetry and molecular. Journal of Biomolecular Structure & Dynamics. 2018;37(7):1747-1763.
28.          Dhar R, Salvi S, Rajan S, Dalal S, Tikkiwal S, Bhagat R, et al. Salmeterol/fluticasone through breath-actuated inhaler versus pMDI: A randomized, double-blind, 12 weeks study. 2015;52(10):1065-72.